Shanghai Pharmaceuticals Holding Co., Ltd
SHPMY
$7.34
-$0.26-3.42%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 40.47B | 39.31B | 38.77B | 38.30B | 38.08B |
| Total Other Revenue | 144.21M | 144.21M | 147.29M | 155.11M | 147.29M |
| Total Revenue | 40.61B | 39.45B | 38.91B | 38.45B | 38.22B |
| Cost of Revenue | 36.21B | 35.23B | 34.80B | 34.39B | 34.12B |
| Gross Profit | 4.40B | 4.23B | 4.11B | 4.06B | 4.11B |
| SG&A Expenses | 2.74B | 2.63B | 2.58B | 2.51B | 2.49B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 89.33M | 89.37M | 35.45M | 16.52M | 19.29M |
| Total Operating Expenses | 39.37B | 38.28B | 37.74B | 37.23B | 36.95B |
| Operating Income | 1.24B | 1.18B | 1.18B | 1.22B | 1.27B |
| Income Before Tax | 1.42B | 1.36B | 1.34B | 1.39B | 1.07B |
| Income Tax Expenses | 407.21M | 395.35M | 393.53M | 381.02M | 292.37M |
| Earnings from Continuing Operations | 1.01K | 967.24 | 945.63 | 1.01K | 781.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -194.39M | -174.07M | -164.65M | -166.11M | -180.34M |
| Net Income | 814.99M | 793.17M | 780.98M | 840.20M | 601.20M |
| EBIT | 1.24B | 1.18B | 1.18B | 1.22B | 1.27B |
| EBITDA | 1.50B | 1.42B | 1.41B | 1.46B | 1.49B |
| EPS Basic | 0.22 | 0.21 | 0.21 | 0.23 | 0.16 |
| Normalized Basic EPS | 0.19 | 0.19 | 0.20 | 0.20 | 0.14 |
| EPS Diluted | 0.22 | 0.21 | 0.21 | 0.23 | 0.16 |
| Normalized Diluted EPS | 0.19 | 0.19 | 0.20 | 0.20 | 0.14 |
| Average Basic Shares Outstanding | 14.84B | 14.84B | 14.77B | 14.83B | 14.85B |
| Average Diluted Shares Outstanding | 14.84B | 14.84B | 14.77B | 14.83B | 14.85B |
| Dividend Per Share | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 |
| Payout Ratio | 52.63% | 49.18% | 50.84% | 58.15% | 81.84% |